Should radioactive iodine therapy be administrated in patient of papillary thyroid carcinoma?
- Author:
Junyu ZHAO
1
;
Jianjun DONG
2
;
Qing SUN
3
;
Huanjun WANG
1
;
Zhongwen ZHANG
1
;
Xiaojun ZHOU
1
;
Lin LIAO
4
Author Information
1. Division of Endocrinology, Department of Internal Medicine, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250014, China.
2. Division of Endocrinology, Department of Internal Medicine, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China.
3. Department of Pathology, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250014, China.
4. Division of Endocrinology, Department of Internal Medicine, Shandong Provincial Qianfoshan Hospital, Jinan, Shandong 250014, China. Email: liaolin@medmail.com.cn.
- Publication Type:Case Reports
- MeSH:
Carcinoma;
radiotherapy;
Carcinoma, Papillary;
radiotherapy;
Humans;
Iodine Radioisotopes;
therapeutic use;
Male;
Middle Aged;
Thyroid Neoplasms;
radiotherapy
- From:
Chinese Medical Journal
2014;127(16):3039-3040
- CountryChina
- Language:English
